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Abstract
Atherosclerotic carotid disease causes about 30% of cerebrovascular ischemia 
transitory or permanent in the world; the severity of symptoms is variable. The 
clinical manifestations are varied from focal neurological alterations to transient or 
permanent vascular events. The treatment of the disease will depend on the location, 
degree, and risk, which can be surgical, endovascular, or medical. Open surgical 
treatment, endarterectomy, has been preferred as the first option and, however, has 
been reported to have associated complications like infection, hematoma, stroke, 
heart attack, restenosis, etc. With the advent of new technologies, endovascular 
treatment has been described as an option in patients with high risk or restenosis.
Keywords: atherosclerotic carotid disease, carotid endarterectomy, endovascular 
treatment, medical management of carotid disease, complications
1. Atherosclerotic disease and carotid stenosis
Atherosclerosis is a chronic disease of the arteries characterized by inflammation 
and plaque building in the arterial wall, eventually leading to stenosis of the vessel. 
Carotid atherosclerosis is associated with the increased risk of cardiovascular 
diseases [1].
Ischemic cardiovascular disease is a combination of progressive atherosclerosis 
and acute thrombotic complications [2].
The risk factors in atherosclerosis can be modifiable or not: non-modifiable are 
genetic predisposition, gender, and age, and modifiable factors are blood pressure, 
smoking, diabetes, cholesterol levels, obesity, and physical activity [2].
The earliest pathologic studies described the predilection of atherosclerosis near 
branch ostia, bifurcations, and bends, suggesting the important component of flow 
dynamics plays an important role in its initiation and development. Atherosclerotic 
plaque tends to form at regions where flow velocity and shear stress are reduced, in 
particular at the carotid bifurcation where disturbances in blood flow deviate from 
a laminar unidirectional pattern. Thus, the unique geometry and flow properties 
presented by the carotid bifurcation contribute [3].
Metabolic syndrome is a clinical entity characterized by multiple risk factors for 
cardiovascular disease and diabetes mellitus such as high-normal or elevated blood 
pressure, hyperglycemia, elevated triglycerides, low high-density cholesterol level, 
and abdominal obesity [4].
The increase of cardiovascular risk related to metabolic syndrome is reported; 
over the past decades, the impact of metabolic syndrome on large arterial vessels 
has been analyzed [4].
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Carotid intima-media thickness has been proven to be a valuable predictor of 
myocardial infarction and ischemic stroke independent of traditional risk factor. 
The intima-media thickness was higher in patients with metabolic syndrome [4].
In the study IMPROVE, a multicenter observational European study, it showed 
that the intima-media thickness was a strong predictor of cardiovascular disease [4].
The maximum intima-media thickness of the common carotid artery, as mea-
sured by carotid artery ultrasound, has been used as a marker of atherosclerosis and 
cardiovascular disease. In contrast, there are reports suggesting that the predictive 
ability of intima-media thickness for cardiovascular disease is inferior than that of 
the carotid plaque score assessed by ultrasonography [5].
Recent studies have focused in adding pharmacological strategies like anti-
thrombotic therapy, lowering lipid levels, improving glycemic control, and address-
ing inflammation present in the metabolic syndrome. On the other hand, patients 
with coronary and peripheral diseases have a high risk of cardiovascular death and 
disabling vascular events [2].
Carotid artery stenosis and lower limb peripheral arterial occlusive disease usu-
ally share the same pathological changes and can coexist. It has been reported that 
the prevalence rate of significant carotid stenosis increased with the stage of lower 
limb peripheral occlusive arterial disease. So the screening for significant carotid 
disease in these patients [6].
Screening for carotid stenosis in patients who are neurologically asymptomatic 
may therefore be acceptable when there are two or more risk factors or when 
ankle/brachial index is less than 0.4 with reevaluation of 6 months. Investigations 
have identified combinations of risks that identify populations in whom the risk 
of stenosis between 50% and 99% approaches 60%. Screening patients in these 
categories who are suitable operative candidates and who would undergo operation 
were the found to have clinically important disease [7].
2. Definition and epidemiology
Stroke diagnosis has been based on the World Health Organization’s definition 
of a focal, occasionally global loss of neurological function lasting >24 h and which 
has a vascular etiology. A transient ischemic attack is defined in a similar way, but 
the duration is <24 h [8].
The principal causes of ischemic carotid territory stroke are thromboembolism 
from the internal carotid artery or middle cerebral artery (25%), small vessel 
intracranial disease (25%), cardiac embolism (20%), and other causes (5%). About 
10–15% of all strokes follow thromboembolism from previously asymptomatic 
internal carotid stenosis >50% [9].
Moderate and severe carotid artery stenosis is an important public health issue; 
this condition affects 10% of the general population by their eighth decade and 
accounts for 10% of all strokes [10].
3. Clinical manifestations
The symptoms of the carotid disease were fist described by Fisher (1951). Stroke 
produced by carotid stenosis is caused by a combination of affection of the blood 
vessels, clotting system, and hemodynamics that in conjunction cause embolism  
or/and low cerebral flow [11].
Carotid atherosclerosis is usually most severe within 2 cm of the bifurcation 
of the common carotid artery and involving the posterior wall of the vessel. The 
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definition of asymptomatic or symptomatic carotid artery stenosis is based on the 
history and physical examination [11].
Symptomatic symptoms include transient ischemic attacks produced by emboli-
zation that causes low flow with inadequate collateral blood supply. The symptoms 
depend on the cerebral artery territory involved, and total carotid artery occlusion 
can cause low flow or embolic ischemic events.
Various features of plaque morphology can be used to identify risk and include 
plaque ulceration, plaque structure and composition, and plaque volume [12].
A history of more than one episode of neurological alterations occurring in the 
same carotid territory is very suggestive of underlying carotid disease. The carotid 
bruit is an important sign over the site of the stenosis; however, is a poor predictor 
for development of stroke; and is not sufficiently predictive of high grade of carotid 
disease. However, 75% of patients with bruit had a moderate to severe stenosis 
(more than 60). Ischemic symptoms reflect ipsilateral ocular and cerebral hemi-
sphere ischemia like partial or complete blindness, hemianopsia, hemiparesis, and 
hemisensory loss [12].
4. Diagnosis
There are four diagnostic modalities to directly image the internal carotid artery: 
cerebral angiography, carotid duplex ultrasound, magnetic resonance angiography, 
and computed tomography angiography.
Cerebral angiography is the gold standard for imaging the carotid arteries; it 
permits an evaluation of the entire carotid artery system, providing information 
about tandem atherosclerotic disease, plaque morphology, and collateral circula-
tion; however, it is invasive, costs high, and has a high risk of morbidity and 
mortality [13].
There are three methods to measure carotid stenosis that predominate world-
wide (NASCET, ECST, and CC):
• The North American Symptomatic Carotid Endarterectomy Trial (NASCET) 
measures the residual lumen diameter at the most stenotic portion and com-
pares it with the normal internal carotid diameter [14].
• The European Carotid Surgery Trial (ECST) measures the lumen diameter at 
the most stenotic portion of the vessel and compares this with the estimated 
probable original diameter at the site of maximum stenosis [15].
• Common carotid (CC) measures the residual lumen diameter at the most 
stenotic portion of the vessel and compares this with the lumen diameter in the 
proximal common carotid artery [15].
Equivalent measurements for the three methods have been determined.
Carotid duplex ultrasound uses B-Mode to help detect focal increases in the 
blood flow velocity indicative of a high-grade carotid stenosis. The peak systolic 
velocity is the most frequently used measurement to gauge the severity of the 
stenosis (end-diastolic velocity, spectral configuration, and carotid index provide 
additional information) and correlate with the residual lumen diameter [16].
The sensitivity reported is 89% and the specificity 84%. It is a noninvasive, 
safe, and relative inexpensive technique, although it has limited utility in obtain-
ing information about plaque composition and intraplaque hemorrhage and is less 
precise in determining stenosis of <50% compared with stenoses of higher degrees. 
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Transcranial Doppler is often used in conjunction with ultrasound carotid duplex to 
evaluate the hemodynamic significance of internal carotid artery stenosis [17].
Magnetic resonance angiography technique is used for evaluating the extracra-
nial carotid arteries and produced a reproducible three-dimensional image of the 
carotid bifurcation with a good sensitivity for detecting high-grade carotid stenosis; 
however, it had been reported overestimated degree [18].
Computed tomography angiography provides an anatomic depiction of the 
carotid artery lumen, allows imaging of adjacent soft tissue structures, and is 
particularly useful when carotid duplex ultrasound is not reliable or when an overall 
view of the vascular field is required. It had a sensitivity and specificity of 97 and 
99%, respectively [19].
In earlier reports, magnetic resonance, angiography, and carotid duplex 
ultrasound had difficulties distinguishing very severe stenosis from occlusion, so 
false-positive and false-negative results occurred [20].
The location most frequently affected by atherosclerosis is the carotid 
bifurcation. Progression of atheromatous plaque results in luminal narrowing, 
often accompanied by ulceration, process that can lead to ischemic stroke and 
transient ischemic attack from embolization, thrombosis, and hemodynamic 
compromise [20].
5. Treatment
5.1 Endarterectomy
The endarterectomy is the choice treatment in those patients with transient 
ischemic attacks or who suffered a cerebral infarction with a minimal sequel [21].  
It is beneficial for symptomatic or asymptomatic patients.
The indications for carotid endarterectomy (CEA) are:
1. Bilateral carotid stenosis: in which the combined death and stroke rates in pa-
tients were almost twice than that of matched patients with unilateral disease 
(5.6% versus 2.4%) [22].
2. Prophylactic carotid endarterectomy: in patients with severe carotid stenosis 
prior to another surgery, it is rarely needed, and a decision to proceed should 
be individualized depending upon the clinician’s best estimate of the risk  
of perioperative stroke.
3. Coronary artery bypass surgery: a new stroke or transient ischemic attack 
occurs in approximately 3% of patients following coronary artery bypass 
grafting (CABG); also in general surgery, the incidence of stroke appears to be 
lower in nonvascular surgical procedures than following cardiac surgery with a 
reported incidence in patients undergoing general anesthesia of less than 0.5%.
4. Vascular procedures: there are not enough trials for prophylactic CEA prior to 
abdominal aortic aneurysm repair or other major peripheral vascular proce-
dures, because of the involvement of significant hemodynamic fluctuations.
5. Patients with intracranial aneurysm: ipsilateral intracranial aneurysms that 
are distal to a cervical internal carotid artery stenosis may be susceptible to 
sudden hemodynamic changes associated with CEA, leading to aneurysm 
rupture [23].
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6. Contraindications for carotid endarterectomy
Absolute: asymptomatic complete carotid occlusion.
Relative contraindications: history of neck radiation, concurrent tracheostomy, 
prior radical neck dissection with or without radiation, contralateral vocal cord paral-
ysis from prior endarterectomy, atypical lesion location, either high or low, that is 
surgically inaccessible, severe recurrent carotid stenosis, unacceptably high risk [24].
Carotid endarterectomy is established as safe and effective by randomized 
controlled trials for reducing the risk of ischemic stroke in both symptomatic and 
asymptomatic patients. However, carotid angioplasty and stenting are proposed as 
alternative for carotid endarterectomy.
Symptomatic carotid disease is defined as focal neurologic symptoms that are 
referable to the appropriate carotid artery distribution including transient ischemic 
attacks or ischemic strokes. The definition is contingent on the occurrence of 
carotid symptoms within the previous 6 months.
Carotid endarterectomy and stenting are recommended in patients with recently 
symptomatic carotid stenosis of 70–99% and a life expectancy of at least 5 years 
who meet all of these conditions: accessible carotid lesion, absence of clinically 
significant cardiac, pulmonary or other diseases that increase greatly the risk of 
anesthesia and surgery, and no prior ipsilateral endarterectomy.
It is suggested that carotid endarterectomy have to be done 2 weeks after a 
nondisabling stroke or transitory stroke, because between the first 48 hours, the 
risk of recurrent stroke elevates compared with later surgery. In patients who have a 
large infarction with brain swelling, hemorrhagic brain infarction and progressing 
stroke have long been thought to have high perioperative risk and expose the patient 
to an increased risk of recurrent stroke, emergent CEA for progressing/fluctuating 
stroke, or crescendo transitory attack that may have a high operative risk.
The risk of stroke can be calculated based on patient age, patient sex, degree of 
carotid stenosis, type of presenting symptomatic event, time since last symptomatic 
event, and carotid plaque morphology.
6.1 Surgical complications in carotid endarterectomy
Carotid endarterectomy complications can usually be related to comorbid condi-
tions or cardiovascular preexisting diseases and also to the surgical technique. Most 
common complications of CEA include myocardial infarction, perioperative stroke, 
postoperative bleeding, and the potential consequences of cervical hematoma, 
nerve injury, surgical site infection, and carotid restenosis. However, the rates of 
complications after carotid endarterectomy is low [25–33].
There are two important trials in which the benefit is higher than the possible 
complications: the European Trial (ICSS) reports a mortality at 120 days of post-op 
of 0.8% and complications of 4.2%. The North American Trial (CREST) [33, 34] 
reported combined results for symptomatic and asymptomatic patients. In 1240 
patients assigned to endarterectomy (47.3% asymptomatic), the 30-day death rate 
was 0.3%, and the rate of any periprocedural (30-day) stroke or death or postpro-
cedural ipsilateral stroke was 2.3%.
Appropriate perioperative medication management is important to reduce the 
risk of cardiovascular and procedure-specific complications.
There are three mains risk factors:
1. Myocardial infarction
2. Stroke
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3. Death
Others:
1. Hyperperfusion syndrome
2. Cervical hematoma
3. Nerve injury
4. Infection
5. Restenosis
There are a lot of risk factors, some of them are:
1. Age (>80 years)
2. Smoking
3. Previous stroke including transient ischemic attack
4. Previous stenosis of carotid artery
5. Special or chronic conditions such as cancer, heart diseases, hypertension, and 
diabetes
6.2 Myocardial infarction
In randomized trials, myocardial infarction has occurred at a slightly higher 
rate for carotid endarterectomy than carotid artery stenting [25, 26, 28–31]; with a 
reported incidence between 0 and 2%, pooled absolute risk of perioperative (30-day) 
myocardial infarction was 0.87%. The risk factors for myocardial infarction included 
older age, coronary heart disease, peripheral artery disease, and carotid restenosis.
6.3 Perioperative stroke
Perioperative stroke is the second most common cause of death in carotid end-
arterectomy [25, 26, 28, 32, 33, 35, 36] with a rate of less than 3% for symptomatic 
patients and less than 5% for the symptomatic patients depending on the indica-
tion of the CEA and the experience of the surgeon. But also there are some factors 
that can contribute to postoperative stroke [28, 37–42] like plaque emboli, platelet 
aggregates, improper flushing, poor cerebral protection, and relative hypotension.
If perioperative stroke is suspected, ultrasound is a good option; but if it shows 
good flow throughout the carotid artery with no thrombosis or intimal flaps, a head 
computed tomography (CT) scan should be obtained to rule out intracranial bleed-
ing [38, 43–45]. If there is access to a hybrid operating room, another approach 
to obtain may be head CT first, and, if no bleeding is identified, intraoperative 
arteriography to identify any correctable lesions is performed [28].
6.4 Hyperperfusion syndrome
It is an uncommon complication of endarterectomy, occurring after carotid 
revascularization in less than 1%; it causes the most postoperative intracerebral 
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hemorrhages and seizures in the first 2 weeks after CEA. It is caused after the 
surgery; because of the small vessels that chronically compensated the patient, and 
after endarterectomy blood flow is restored to a normal or elevated perfusion pres-
sure and those vessels are unable to vasoconstrict sufficiently to protect the capil-
lary bed, causing edema and hemorrhage and clinical manifestations. Hypertension 
is a frequent predecessor of the syndrome, underscoring the importance of good 
perioperative blood pressure control [46].
Hyperperfusion syndrome appears to be more likely with revascularization of a 
high-grade (80% or greater) stenosis.
Hyperperfusion syndrome is characterized by the following clinical features:
1. Headache ipsilateral to the revascularized internal carotid, typically im-
proved in upright posture, may herald the syndrome in the first week after 
endarterectomy.
2. Focal motor seizures are common, sometimes with postictal Todd’s paralysis 
mimicking post-endarterectomy stroke from carotid thrombosis.
3. Intracerebral hemorrhage is the most feared complication, occurring in 
 approximatelys 0.6% of patients after CEA, usually within 2 weeks of surgery.
Treatment consists of prevention, strict control of postoperative hypertension 
maintaining a systolic blood pressure below 150 mmHg, and using labetalol, nitro-
prusside, and nitroglycerin aggressively. If complication is suspected in any patient 
with severe headache following CAE, a head CT is required to confirm or discard 
this syndrome [46, 47].
6.5 Cervical hematoma
This is a catastrophic and real urgent complication, because it can result in abrupt 
loss of the airway, with an incidence of 4% after CAE and requiring a re-exploration 
of the neck. Uncontrolled hypertension during emergence from anesthesia or in the 
postoperative period can also lead to hematoma formation [26, 35, 48].
6.6 Nerve injury
Cranial nerve or other nerve injuries occur in approximately 5% of patients 
following carotid endarterectomy [27, 33].
According to the European Carotid Surgery Trial, cranial nerve injury rate 
declined to 3.7%. In the Vascular Study Group of New England (VSGNE) database, 
the overall rate of nerve injury at discharge was 5.6%; 0.7% of patients had more 
than one nerve affected.
Hypoglossal nerve is the most frequently injurie manifested by a deviation of 
the tongue to the side of the injury, the facial nerve is the second one resulting in 
paresis of the lateral aspect of the orbicularis oris muscle with asymmetric smile; 
and the vagus nerve which result in unilateral vocal cord paralysis, glossopharyn-
geal nerve can be damaged with excessive dissection in the carotid bifurcation 
[26, 32, 36].
Injury to the sympathetic nerves can result in Horner’s syndrome or, rarely, an 
entity called “first bite syndrome.” Horner’s syndrome can be complete (miosis, 
ptosis, anhidrosis) or partial (no anhidrosis) [29].
First bite syndrome is characterized by unilateral pain in the parotid region 
after the first bite of each meal felt to be due to sympathetic denervation of the 
parotid gland.
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6.7 Infection
Surgical site/patch infection (SSI) rarely occurs following carotid endarterec-
tomy, and, when they occur, most are superficial and self-limiting with antibiotic 
treatment. The prophylaxis is the best practice to prevent SSI.
Clinically the patient will have neck swelling and drainage from incision in acute 
events; in delayed infections, a draining sinus tract or pulsatile neck mass could 
be indicative of a carotid pseudoaneurysm. If infection persists, a patch excision 
is indicated with early carotid ligation, reconstruction with autogenous vein, or 
bypass; nowadays the use of negative pressure systems is a good option to perform 
a better treatment of these infections, resulting in better outcomes and reducing 
complications of a new exploratory surgery in these patients [3, 13, 19, 25–41].
6.8 Carotid restenosis
The pathology of the restenotic lesion is related to the time of presentation after 
initial surgery. Most patients with restenosis are asymptomatic and are identified 
with routine follow-up carotid imaging [29].
It is called early restenosis in those that occur within 2–3 years after CEA and 
late in those that occur more than 2–3 years after surgery. Patients at increased risk 
for restenosis include those below age 65, smokers, and women. Patch angioplasty 
appears to be associated with a decreased risk of long-term recurrent stenosis 
compared with primary closure [29, 31].
Reintervention is indicated in patients who develop neurologic symptoms refer-
able to the carotid artery and those with restenosis >80% [29, 45].
6.9 Endovascular treatment
Carotid artery angioplasty and stenting are the standard for endovascular carotid 
intervention that is preferred for most patients with symptomatic internal carotid 
atherosclerosis. Patients with symptomatic carotid disease treated by endarterec-
tomy that are considered to be less invasive have long-term benefits; nevertheless, it 
is reported that patients have an increased risk for poor outcomes with endarterec-
tomy such as stroke periprocedural (30 days). So it is recommended in patients with 
70–99% stenosis with the following conditions: not suitable surgical access, stenosis 
radiation induced, restenosis after endarterectomy, and clinically significant 
cardiac, pulmonary, or other disease that increment risk.
Low dose of aspirin treatment is recommended for all patients who are having 
an endarterectomy and have to be continued for at least 3 months after surgery; 
posterior only is indicated with cardiovascular disease.
The endovascular treatment is nowadays the first-line treatment for many 
vascular diseases. The percutaneous intraluminal angioplasty (PTA) consists in 
dilatation with a balloon for stenotic lesions, making a dehiscence effect, leading 
to fracture and separation of the arterial media from the intima; it was the first 
performed endovascular treatment. The introduction of stents was a major step in 
the evolution of the endovascular management of carotid stenosis [49].
There are a lot of diapositives that can be used in the endovascular treatment 
[22, 41, 50]; some of them are the following:
1. Cryoplasty is a type of balloon angioplasty that has liquid nitrous oxide to 
get inflated and uses cooling a-10°C (14°F) and pressure to dilate the plaque 
and vessel wall. It is well studied in iliac, infrainguinal, femoropopliteal, and 
popliteal lesions.
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2. Focal pressure balloon was designed to reduce dissection and restenosis and to 
exhibit focal pressure to the lesions; it is used in infrapopliteal lesions.
3. Drug-coated balloon: drug-eluting stents (DES) achieve local administration 
of an agent capable of inhibiting intimal hyperplasia without systemic side 
effects. Cypher stents release sirolimus which has a potent immunosuppressive 
drug that controls intimal hyperplasia. TAXUS is a second-generation DES, 
with greater durability and which reduces restenosis. These devices are used in 
femoropopliteal lesions.
4. Stents are a method to reduce the incidence of restenosis or address balloon 
PTA failure due to elastic recoil or dissection. They are classified as balloon-
expanding (BES) and self-expanding stents and also either as bare metal or 
covered stents. Self-expanding stents are composed typically of nitinol.
5. Stent grafts
a. Balloon-expanding stent grafts can be expanded beyond the stated stent 
diameter; they are used for tracheobronchial strictures but not for PAD, 
for iliac or renal artery vascular beds, for occlusive lesions, as well as for 
perforation after PTA or stenting.
b. Self-expanding stent grafts are used for various applications and in femo-
ropopliteal disease and biliary applications.
c. Drug-eluting stents have been associated with improved patency for the 
treatment of PAD compared to conventional balloon angioplasty. These 
are loaded with paclitaxel and sirolimus usually using polymers; these are 
used for femoropopliteal disease.
d. Multilayer stents:
i. Multilayer flow modulator (MFM) is designed to exclude peripheral or 
visceral aneurysm while maintaining branch vessel flow. It is a three-
dimensional braided tube composed of multilayer wire without any 
covering prostheses.
ii. Bioabsorbable stents are initially developed for coronary intervention, 
now is used also for peripheral arterial beds.
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